Creation of the necessary analytical quality for generating and using reference intervals

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 7, 2004, Pages 851-857

  Klein, Gerhard ^a   Junge, Wolfgang ^b  

^a ROCHE DIAGNOSTICS GMBH   (Germany)

^b LKF Laboratorium für Klinische Forschung GmbH   (Germany)

Author keywords

Calibration stability; Instrument perfomance; Long term analytical quality; Method development; Method evaluation; Method specification and description; Quality of performance characteristics

Indexed keywords

ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MEDICAL INSTRUMENTATION; METHODOLOGY; PRIORITY JOURNAL; QUALITY CONTROL; REFERENCE VALUE; STANDARDIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URINALYSIS;

CALIBRATION; CLINICAL CHEMISTRY TESTS; HUMANS; METHODS; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; REFERENCE VALUES;

EID: 4344710570     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.139     Document Type: Article

References (34)

1. National Committee of Clinical Laboratory Standards. How to define and determine reference intervals in the clinical laboratory; approved guideline, 2nd ed. NCCLS document C28-A2 [ISBN 1-56238-406-6], Wayne, PA: 19087-1898 USA, 2000.
2. Solberg HE, Stamm D. International Federation of Clinical Chemistry (IFCC). Approved recommendation on the theory of reference values. Part 4. Control of analytical variation in the production, transfer and application of reference values. J Clin Chem Clin Biochem 1991;29:531-5.
3. European Committee for Standardization. Quality management systems - requirements. EN ISO 9001:2000.
4. National Committee of Clinical Laboratory Standards. User demonstration of performance for precision and accuracy; approved guideline, NCCLS document EP15-A [ISBN 1-56238-451-1], Wayne, PA: 19087-1898 USA, 2001.
5. Fraser CG, Hyltoft Petersen P, Ricos C, Haeckel R. Quality specifications. In: Haeckel R, editor. Evaluation methods in laboratory medicine. Weinheim: VCH, 1993;87-99.
6. Stöckl D, Baadenhuisen H, Fraser CG, Libeer J-C, Hyltoft Petersen P, Ricos C. Desirable routine analytical goals for quantities assayed in serum. Eur J Clin Chem Clin Biochem 1995;33:157-69.
7. Fraser CG, Kallner A, Kenny D, Hyltoft Petersen P. Strategies to set global analytical quality specifications in laboratory medicine. Consensus Statement, Stockholm 1999. Scand J Clin Lab Invest 1999;59:585.
8. Ricos C, Alvarez F, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59:491-500.
9. Panteghini M. Performance of today's cardiac troponin assays and tomorrow's. Clin Chem 2002;48:809-10.
10. In Vitro Diagnostic Medical Devices. Measurement of quantities in biological samples, metrological traceability of values assigned to calibrators and control materials. prEN ISO 17511:2002.
11. In Vitro Diagnostic Medical Devices. Measurement of quantities in biological samples, metrological traceabiity for catalytic concentration of enzymes assigned to calibrators and control materials. prEN ISO 18153:2002.
12. Doumas BT, Kwok-Cheung PP, Perry BW, Jendrzejczak B, McComb RB, Schaffer R, et al. Candidate reference method for determination of total bilirubin in serum: development and validation. Clin Chem 1985; 31:1779-89.
13. Santambrogio P, Cozzi A, Rovida E, Albertini A, Arosio P. Production and characterization of recombinant heteropolymers of human ferritin H and L chains. J Biol Chem 1993;268:12744-8.
14. Junge W, Wilke B, Halabi A, Klein G. Determination of reference intervals for serum creatinine, creatinine excretion and creatinine clearance with an enzymatic and a modified Jaffe method. Clin Chim Acta 2004;344:137-48.
15. Lorentz K. Approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 9. IFCC method for α-amylase (1,4-α-D-glucan-4-glucanohydrolase, EC 3.2.1.1 . Clin Chem Lab Med 1998;36:185-203.
16. Junge W, Wortmann W, Wilke B, Waldenström J, Kurrle-Weittenhiller A, Finke J, et al. Development and evaluation of assays for the determination of total and pancreatic amylase at 37°C according to the principle recommended by the IFCC. Clin Biochem 2001; 34:607-15.
17. Ceriotti F, Férard G, Ferrero CA, Ehlers G, Gella FJ, Hölzel W, et al. Catalytic concentration of α-amylase determined by IFCC reference method at 37°C. European Commission. IRMM-IFCC information, reference materials, EUR 19927 EN (ISBN 92-894-1980-6). Luxembourg 2001.
18. Fischbach F, Zawta B. Age-dependent reference limits of several enzymes in plasma at different measuring temperatures. Klin Lab 1992;38:555-61.
19. Thienpont LM, Van Uytfanghe K, Cabaleiro DR. Metrological traceability of calibration in the estimation and use of common medical decision-making criteria. Clin Chem Lab Med 2004;42:842-850.
20. Büttner J. Evaluation of diagnostic and prognostic measures. In: Haeckel R, editor. Evaluation methods in laboratory medicine. Weinheim: VCH, 1993:1-46.
21. National Committee of Clinical Laboratory Standards. Preliminary evaluation of quantitative clinical laboratory methods; approved guideline, NCCLS document EP10-A [ISBN 1-56238-348-5], Wayne, PA: 19087-1898 USA, 1998.
22. Köbberling J, Trampisch HJ, Windeler J. Memorandum for the evaluation of diagnostic measures. Ed. by the working group " Methods for prognosis and decision making" in the GMDS. J Clin Chem Clin Biochem 1990;28:873-9.
23. Haeckel R, Busch EW, Jennings RD, Truchaud A. Guidelines for the evaluation of analyzer in clinical chemistry. ECCLS document 3, no. 2. Berlin: Beuth Verlag, 1986.
24. Haeckel R, Römer M, Sonntag O, Vassault C, Naudin C. Recommendations for the multicentre evaluation of analytical systems in clinical chemistry. In: Haeckel R, editor. Evaluation methods in laboratory medicine. Weinheim: VCH, 1993:47-69.
25. Redondo FL, Bermudez P, Cocco C, Colella F, Graziani MS, Fiehn W, et al. Evaluation of Cobas Integra 800 under simulated routine conditions in six laboratories. Clin Chem Lab Med 2003;41:365-81.
26. Bundesärztekammer: Richtlinie der Bundesärztekammer zur Qualitätssicherung quantitativer laboratoriumsmedizinischer Untersuchungen. Dtsch Ärztebl 2001; 98:A2747-59.
27. Baudner S, Bienvenu J, Blirup-Jensen S, Carlström A, Johnson AM, Milford-Ward A, et al. The certification of a matrix reference material for immunochemical measurement of 14 human serum proteins, CRM 470. Commission of the European Communities. BCR information, reference materials, EUR 15234 EN (ISSN 1018-5593), Brussels 1993:1-172.
28. Johnson AM, Guder WG. Albumin. In: Ritchie RF, Novolotskaia O, editors. Serum proteins in clinical medicine. Scarborough: Foundation for Blood Research, 1996:1-10.
29. National Kidney Foundation. K/DOQI. Clinical practice guidelines for chronic kidney disease: Part 5. Evaluation of laboratory measurements for clinical assessment of kidney disease. Guideline 4. Estimation of GFR. Am J Kidney Dis 2002;39:S76-110.
30. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
31. Schlebusch H, Liappis N, Kalina E, Klein G. High sensitive CRP and creatinine: reference intervals from infancy to childhood. J Lab Med 2002;26:41-6.
32. Thomas L. Creatinine. In: Thomas L, editor. Clinical laboratory diagnostics, 1st ed. Frankfurt: TH-Books Verlagsgesellschaft mbH, 1998;366-71.
33. Schumann G, Klauke R. New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clin Chim Acta 2003;327:69-79.
34. Klein G, Berger A, Bertholf R, Braun S, Brockett M, Cottenceau D, et al. Multicenter evaluation of liquid reagents for CK, CK-MB and LDH with determination of reference intervals on Hitachi systems [abstract]. Clin Chem 2001;47:A30.